Skip to main content
CBZ
NYSE Trade & Services

CBIZ Q2 Earnings Drop 56% as Acquisition Looms; Guidance Pulled

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Negative
Importance info
8
Price
$54.5
Mkt Cap
$2.505B
52W Low
$24.29
52W High
$77.91
52W Position info
124% above low
Off High info
30% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

CBZ has more than doubled off its 52-week low of $24.29.

Summary

CBIZ reported a steep 55.6% drop in Q2 net income and withdrew its 2026 guidance, citing the pending acquisition by Grant Thornton. The results were weighed down by integration costs, a legal settlement, and an ESPP correction.


Key Events · Earnings and Guidance · CBZ

  • Q2 Net Income Plunges 55.6%

    Net income fell to $19M from $42M a year ago, with GAAP EPS of $0.31 vs. $0.66. Adjusted diluted EPS declined 8.1% to $0.91.

  • Full-Year Guidance Withdrawn

    CBIZ suspended its fiscal 2026 outlook and canceled its earnings call, citing the pending acquisition by Grant Thornton.

  • Integration and Legal Costs Weigh on Margins

    Q2 included $14.8M in integration costs, a $7.2M legal settlement loss, and a $10.4M ESPP correction expense, compressing margins.

  • First-Half Results Show Modest Growth

    First-half net income rose 4.1% to $171M, with GAAP EPS up 9.7% to $2.83, aided by a $58M acquisition-related gain in Q1.


Analysis · CBZ · Trade & Services

A 55.6% plunge in second-quarter net income to $19 million, with GAAP EPS down 53% to $0.31, reflects the weight of higher integration costs, a legal settlement, and an ESPP correction. Adjusted EBITDA also contracted, falling 14.3%. Adding to the uncertainty, management withdrew its full-year 2026 outlook and canceled the earnings call, pointing to the pending $5 billion all-cash acquisition by Grant Thornton. While first-half results managed modest growth, the sharp Q2 deterioration and the suspension of forward guidance underscore near-term operational headwinds ahead of the deal's expected Q4 close.

At the time of this filing, CBZ was trading at $54.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $24.29 to $77.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBZ - Latest Insights

CBZ
Jul 29, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $46.70
Real-time Price: $54.95 info
Change: +$8.25 (+18%) info
Market Cap: $2.505B info
CBZ
Jul 29, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $46.70
Real-time Price: $54.95 info
Change: +$8.25 (+18%) info
Market Cap: $2.505B info
CBZ
Apr 30, 2026, 9:01 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $34.80
Real-time Price: $54.95 info
Change: +$20.15 (+58%) info
Market Cap: $2.505B info
CBZ
Apr 30, 2026, 8:55 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $34.80
Real-time Price: $54.95 info
Change: +$20.15 (+58%) info
Market Cap: $2.505B info
CBZ
Apr 29, 2026, 4:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $34.19
Real-time Price: $54.95 info
Change: +$20.76 (+61%) info
Market Cap: $2.505B info